Nikulaa Parachuri

751 total citations
40 papers, 381 citations indexed

About

Nikulaa Parachuri is a scholar working on Ophthalmology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nikulaa Parachuri has authored 40 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Ophthalmology, 20 papers in Immunology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nikulaa Parachuri's work include Retinal Diseases and Treatments (20 papers), Biosimilars and Bioanalytical Methods (14 papers) and Retinal and Optic Conditions (10 papers). Nikulaa Parachuri is often cited by papers focused on Retinal Diseases and Treatments (20 papers), Biosimilars and Bioanalytical Methods (14 papers) and Retinal and Optic Conditions (10 papers). Nikulaa Parachuri collaborates with scholars based in United States, India and Italy. Nikulaa Parachuri's co-authors include Nilesh Kumar, Ashish Sharma, Baruch D. Kuppermann, Francesco Bandello, Anat Loewenstein, Anat Loewenstein, Carl D. Regillo, Rohini Sharma, David S. Boyer and Srinivas R. Sadda and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Ophthalmology and British Journal of Ophthalmology.

In The Last Decade

Nikulaa Parachuri

37 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nikulaa Parachuri United States 11 306 190 58 43 24 40 381
Serafín González United States 5 586 1.9× 352 1.9× 13 0.2× 75 1.7× 9 651
Maria Teresa Sandinha United Kingdom 10 190 0.6× 139 0.7× 5 0.1× 19 0.4× 11 0.5× 16 217
Nenad Vukojević Croatia 7 86 0.3× 91 0.5× 10 0.2× 21 0.5× 3 0.1× 25 163
S Longstaff United Kingdom 9 215 0.7× 125 0.7× 2 0.0× 14 0.3× 14 0.6× 15 257
Jean Jacques De Bruycker Canada 5 56 0.2× 15 0.1× 8 0.1× 9 0.2× 4 0.2× 8 99
Clara Malagón Colombia 7 50 0.2× 4 0.0× 47 0.8× 20 0.5× 4 0.2× 11 141
Cathleen M. McCabe United States 11 303 1.0× 193 1.0× 6 0.1× 16 0.4× 1 0.0× 17 360
Pierre‐Edouard Gavand France 5 10 0.0× 28 0.1× 66 1.1× 8 0.2× 1 0.0× 8 144
Marcel du Moulin Germany 8 15 0.0× 5 0.0× 30 0.5× 71 1.7× 3 0.1× 8 175
Sabrina Porta Argentina 4 6 0.0× 37 0.2× 73 1.3× 11 0.3× 9 0.4× 6 159

Countries citing papers authored by Nikulaa Parachuri

Since Specialization
Citations

This map shows the geographic impact of Nikulaa Parachuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikulaa Parachuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikulaa Parachuri more than expected).

Fields of papers citing papers by Nikulaa Parachuri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikulaa Parachuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikulaa Parachuri. The network helps show where Nikulaa Parachuri may publish in the future.

Co-authorship network of co-authors of Nikulaa Parachuri

This figure shows the co-authorship network connecting the top 25 collaborators of Nikulaa Parachuri. A scholar is included among the top collaborators of Nikulaa Parachuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikulaa Parachuri. Nikulaa Parachuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Ashish, Se Joon Woo, Christopher S. Lee, et al.. (2025). Aflibercept 2 mg biosimilars—will they lead the Anti-VEGF biosimilar world globally. Eye. 39(6). 1026–1027. 1 indexed citations
2.
Sharma, Ashish, Anat Loewenstein, Nikulaa Parachuri, et al.. (2023). Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?. Eye. 38(2). 244–245. 3 indexed citations
3.
Sharma, Ashish, et al.. (2022). Ranizurel safety evaluation in real-world -(RaSER) study. American Journal of Ophthalmology Case Reports. 25. 101358–101358. 6 indexed citations
4.
Sharma, Ashish, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello, & Baruch D. Kuppermann. (2022). Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity. Eye. 37(1). 4–5. 1 indexed citations
5.
Sharma, Ashish, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello, & Baruch D. Kuppermann. (2022). Fear of safety compromise with biosimilar anti-VEGF—perception or truth. Eye. 36(11). 2086–2087. 3 indexed citations
6.
Sharma, Ashish, et al.. (2021). Semaglutide and the risk of diabetic retinopathy—current perspective. Eye. 36(1). 10–11. 29 indexed citations
7.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2021). Ranibizumab Biosimilar (Razumab) vs Innovator Ranibizumab (Lucentis) in neovascular age-related macular degeneration (n-AMD)- efficacy and safety (BIRA study). Eye. 36(5). 1106–1107. 13 indexed citations
8.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2021). Understanding the Mechanisms of Fluid Development in Age-Related Macular Degeneration. Ophthalmology Retina. 5(2). 105–107. 8 indexed citations
9.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2021). Brolucizumab—foreseeable workflow in the current scenario. Eye. 35(6). 1548–1550. 14 indexed citations
10.
Sharma, Ashish, Nikulaa Parachuri, Nilesh Kumar, et al.. (2021). Terms non-exudative and non-neovascular: awaiting entry at the doors of AMD reclassification. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(6). 1381–1383. 6 indexed citations
11.
Sharma, Ashish, Nikulaa Parachuri, Nilesh Kumar, Baruch D. Kuppermann, & Francesco Bandello. (2021). The Port Delivery System with ranibizumab—journey of mitigating vitreous hemorrhage. Eye. 36(3). 488–489. 8 indexed citations
12.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Brolucizumab—early real-world experience: BREW study. Eye. 35(4). 1045–1047. 55 indexed citations
13.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Correction: Brolucizumab—early real-world experience: BREW study. Eye. 35(4). 1286–1286. 2 indexed citations
14.
Sheth, Jay, Giridhar Anantharaman, Nilesh Kumar, et al.. (2020). Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum. Eye. 34(9). 1501–1503. 11 indexed citations
15.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). Brolucizumab and immunogenicity. Eye. 34(10). 1726–1728. 41 indexed citations
16.
Kaur, Rajwinder, Nilesh Kumar, Nikulaa Parachuri, et al.. (2020). MII RetCam assisted smartphone-based fundus imaging (MSFI)—A boon for paediatric retinal imaging. Eye. 34(8). 1307–1309. 8 indexed citations
17.
Sharma, Ashish, Nikulaa Parachuri, Nilesh Kumar, et al.. (2020). Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation. British Journal of Ophthalmology. 105(3). 297–298. 5 indexed citations
18.
Sharma, Ashish, Nilesh Kumar, Nikulaa Parachuri, et al.. (2019). Ranibizumab port delivery system (RPDS): realising long awaited dream of prolonged VEGF suppression. Eye. 34(3). 422–423. 9 indexed citations
19.
Sharma, Ashish, Nikulaa Parachuri, Nilesh Kumar, et al.. (2019). Subfoveal Neurosensory Detachment Flattening and Observe (SNF-Ob): A Novel Approach in Diabetic Macular Edema Management. Ophthalmology Retina. 3(11). 1009–1011.
20.
Sharma, Ashish, Mohd Hafeez Faridi, Nilesh Kumar, et al.. (2019). Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data. Eye. 34(6). 1008–1009. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serafín González Breakdown of academic impact, for papers by Maria Teresa Sandinha Breakdown of academic impact, for papers by Nenad Vukojević Breakdown of academic impact, for papers by S Longstaff Breakdown of academic impact, for papers by Jean Jacques De Bruycker Breakdown of academic impact, for papers by Clara Malagón Breakdown of academic impact, for papers by Cathleen M. McCabe Breakdown of academic impact, for papers by Pierre‐Edouard Gavand Breakdown of academic impact, for papers by Marcel du Moulin Breakdown of academic impact, for papers by Sabrina Porta
Rankless by CCL
2026